focus -WSS

focus

author：comprehensive 2025-09-29 22:51:21 - browse：5215

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： One Duchenne patient's bittersweet hope for new treatment

explore

WSS

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Cancer drug shortages' outsize impact on ovarian cancer patients

Digital health funding stays low as a new reality sets in

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

New details revealed about Purdue's marketing of OxyContin

Vermont grapples with historic flooding as more rainstorms head for Northeast

knowledge

focus

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Living with Hashimoto's and celiac disease, and med school, too

Bright Health sells Medicare Advantage business to Molina

Superbugs, antibiotic resistance get scrutiny in congress

In Memoriam: Notable people who died in 2023

As Maui death toll rises, number of missing remains unclear

After affirmative action ruling, medical educators look to 'holistic review'

After half a century, Israel moves to evict squatter from his cave home on the beach

Bright Health sells Medicare Advantage business to Molina

Living with Hashimoto's and celiac disease, and med school, too

knowledge

Cancer drug shortages' outsize impact on ovarian cancer patients

New definition of a human embryo proposed amid rapid advances

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

The pain doctors face in trying to build their families

EU fines Illumina $475 million over Grail acquisition

One Duchenne patient's bittersweet hope for new treatment

Wikipedia

explore

entertainment

leisure time